FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152808521> ?p ?o ?g. }

• W2152808521 endingPage "1337" @default.
• W2152808521 startingPage "1331" @default.
• W2152808521 abstract "Type 1 diabetes (T1D) is often first recognized when signs and symptoms occur, yet the pathogenetic development of T1D usually begins years before that. Pancreatic autoantibodies commonly become elevated long before diagnosis (1). Although data indicate that the first-phase insulin response (FPIR) is also abnormal well before diagnosis (2–5), the development and progression of metabolic abnormalities had not been well characterized until the recent performance of T1D prevention trials (6–8). The unique designs of these trials provided the opportunity to perform longitudinal studies that have yielded new insights into metabolic changes that occur during the progression to T1D. This review will describe what we have learned about the metabolic natural history of T1D from the Diabetes Prevention Trial–Type 1 (DPT-1).### A description of DPT-1.DPT-1 included two separate trials, the parenteral and oral insulin trials (6,7). The objective of both trials was to delay or prevent the occurrence of T1D by interfering with the immunologic processes that result in the disorder. The parenteral insulin trial consisted of an intervention group that received subcutaneous ultralente insulin at a dose of 0.125 units/kg twice daily and a control group that received no insulin. The intervention group was admitted annually to a unit for 4 days during which a continuous infusion of recombinant human regular insulin was administered. The oral insulin trial included an intervention group, which received a once-daily dose of 7.5 mg recombinant human insulin crystals, and a placebo control group.In both trials, individuals were required to be nondiabetic, aged 1–45 years, and first- or second-degree relatives of T1D patients. Two phases determined further eligibility for the trials. In the screening phase, the relatives were tested for islet cell autoantibody (ICA) positivity. Those positive then participated in a risk assessment phase. This included an intravenous glucose tolerance test …" @default.
• W2152808521 created "2016-06-24" @default.
• W2152808521 creator A5005436471 @default.
• W2152808521 creator A5025956771 @default.
• W2152808521 creator A5052455661 @default.
• W2152808521 creator A5057311334 @default.
• W2152808521 date "2012-05-14" @default.
• W2152808521 modified "2023-10-11" @default.
• W2152808521 title "The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1" @default.
• W2152808521 cites W1988519907 @default.
• W2152808521 cites W1993696484 @default.
• W2152808521 cites W2008480928 @default.
• W2152808521 cites W2011433684 @default.
• W2152808521 cites W2019081336 @default.
• W2152808521 cites W2037499365 @default.
• W2152808521 cites W2040251300 @default.
• W2152808521 cites W2043879867 @default.
• W2152808521 cites W2044679483 @default.
• W2152808521 cites W2048047313 @default.
• W2152808521 cites W2053670472 @default.
• W2152808521 cites W2073851267 @default.
• W2152808521 cites W2074463323 @default.
• W2152808521 cites W2074845177 @default.
• W2152808521 cites W2082204706 @default.
• W2152808521 cites W2086959993 @default.
• W2152808521 cites W2088090464 @default.
• W2152808521 cites W2089811173 @default.
• W2152808521 cites W2093634960 @default.
• W2152808521 cites W2096485353 @default.
• W2152808521 cites W2098988589 @default.
• W2152808521 cites W2101947332 @default.
• W2152808521 cites W2105271024 @default.
• W2152808521 cites W2112144440 @default.
• W2152808521 cites W2114039266 @default.
• W2152808521 cites W2119813462 @default.
• W2152808521 cites W2121595329 @default.
• W2152808521 cites W2124855406 @default.
• W2152808521 cites W2124924763 @default.
• W2152808521 cites W2130552423 @default.
• W2152808521 cites W2136015010 @default.
• W2152808521 cites W2145193656 @default.
• W2152808521 cites W2145575612 @default.
• W2152808521 cites W2152704466 @default.
• W2152808521 cites W2157324984 @default.
• W2152808521 cites W2158880005 @default.
• W2152808521 cites W2160111029 @default.
• W2152808521 cites W2161201404 @default.
• W2152808521 cites W2164252720 @default.
• W2152808521 cites W2164825249 @default.
• W2152808521 cites W2170472882 @default.
• W2152808521 cites W2326347426 @default.
• W2152808521 cites W2334639754 @default.
• W2152808521 cites W2341744959 @default.
• W2152808521 cites W2776280 @default.
• W2152808521 cites W4235093819 @default.
• W2152808521 cites W4247937483 @default.
• W2152808521 cites W4300788853 @default.
• W2152808521 cites W614574849 @default.
• W2152808521 doi "https://doi.org/10.2337/db11-1660" @default.
• W2152808521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3357303" @default.
• W2152808521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22618768" @default.
• W2152808521 hasPublicationYear "2012" @default.
• W2152808521 type Work @default.
• W2152808521 sameAs 2152808521 @default.
• W2152808521 citedByCount "50" @default.
• W2152808521 countsByYear W21528085212013 @default.
• W2152808521 countsByYear W21528085212014 @default.
• W2152808521 countsByYear W21528085212015 @default.
• W2152808521 countsByYear W21528085212016 @default.
• W2152808521 countsByYear W21528085212017 @default.
• W2152808521 countsByYear W21528085212018 @default.
• W2152808521 countsByYear W21528085212019 @default.
• W2152808521 countsByYear W21528085212020 @default.
• W2152808521 countsByYear W21528085212021 @default.
• W2152808521 countsByYear W21528085212022 @default.
• W2152808521 crossrefType "journal-article" @default.
• W2152808521 hasAuthorship W2152808521A5005436471 @default.
• W2152808521 hasAuthorship W2152808521A5025956771 @default.
• W2152808521 hasAuthorship W2152808521A5052455661 @default.
• W2152808521 hasAuthorship W2152808521A5057311334 @default.
• W2152808521 hasBestOaLocation W21528085211 @default.
• W2152808521 hasConcept C126322002 @default.
• W2152808521 hasConcept C134018914 @default.
• W2152808521 hasConcept C2777180221 @default.
• W2152808521 hasConcept C2777391703 @default.
• W2152808521 hasConcept C2780609358 @default.
• W2152808521 hasConcept C2780833929 @default.
• W2152808521 hasConcept C555293320 @default.
• W2152808521 hasConcept C71924100 @default.
• W2152808521 hasConceptScore W2152808521C126322002 @default.
• W2152808521 hasConceptScore W2152808521C134018914 @default.
• W2152808521 hasConceptScore W2152808521C2777180221 @default.
• W2152808521 hasConceptScore W2152808521C2777391703 @default.
• W2152808521 hasConceptScore W2152808521C2780609358 @default.
• W2152808521 hasConceptScore W2152808521C2780833929 @default.
• W2152808521 hasConceptScore W2152808521C555293320 @default.
• W2152808521 hasConceptScore W2152808521C71924100 @default.
• W2152808521 hasIssue "6" @default.

• next